NEW YORK and TORONTO and HERZLIYA, Israel, May 15, 2023 , the largest and fastest growing medical cannabis company outside of North America, is pleased to announce that its Chairman and. | May 15, 2023
NEW YORK, TORONTO, and HERZLIYA, Israel, May 15, 2023 InterCure Ltd. today announced that Alexander Rabinovitch, CEO of InterCure, will participate in the Cowen 3rd Annual European Cannabis. | May 15, 2023
Achieved record revenues of $40 million for the first quarter Annualized revenue run rate of $159 million Adjusted EBITDA of $6 Million Strong balance sheet with over $45 million. | May 15, 2023
NEW YORK and TORONTO and HERZLIYA, Israel, April 25, 2023 InterCure Ltd. , the leading medical cannabis company outside of North America announces that on April 24, 2023, it was informed. | April 25, 2023
NEW YORK, TORONTO, and HERZLIYA, Israel, April 24, 2023 InterCure Ltd. , the leading cannabis company outside of North America, announces that on April 23, 2023, it was informed that an. | April 24, 2023